Top Links

Articles Related to LYM

Intravascular Large B-Cell Lymphoma, an Updated Review

Intravascular large B-cell lymphoma (IVBCL) is a rare but aggressive form of non-Hodgkin lymphoma. It is characterized by the malignant proliferation of lymphocytic tumor cells in the lumens of capillaries, small arterioles, and post-capillary venules. There exists two clinical variants: the Asian variant and the Western variant. The former is associated with neurologic and dermatologic signs and symptoms, whereas the latter often presents with splenomegaly, jaundice, and hemophagocytes. Lymphadenopathy is uncommon, and patients typically have nonspecific symptom
View complete article: PDF  |  Full-text

The Impact of Exploring Chromosome Philadelphia like on the Prognosis of Children and Teenager ALL

Acute lymphoblastic leukemia (ALL) is considered as the most common pediatric malignancy with 80% of frequency in children between 1 and 10 years old. With the evolution of science, improved diagnosis and adapted treatment, all survival rates increased to a possibility of 80%. Philadelphia chromosome like acute lymphoblastic leukemia (Ph-Like ALL) is a recent genetic discovery characterized by a gene expression profile and high frequency of IKZF1 gene alteration similar to that of BCR-ABL1 positive ALL with a poor outcome.
View complete article: PDF  |  Full-text

Association of ACE I/D rs4646994 and ACE2 rs2285666 Receptor Gene Polymorphisms with SARS-CoV-2 Infection in Bangladeshi People

Covid-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which hit the world in December 2019 is one of the worst medical emergencies people have ever encountered. Human angiotensin I converting enzyme 2 (ACE2) is the entry path of this virus to the host that regulates the renin-angiotensin-aldosterone system (RAAS). Hypothesis: Susceptibility to SARS-CoV-2 infection may be affected by ACE rs4646994 and ACE2 rs2285666 polymorphisms.
View complete article: PDF  |  Full-text

Leptin Receptor Gene Variant Rs1137101 and Ghrelin Gene Variant Rs696217 are Associated with Body Mass Index in Brazilian Population: A Case-Control Study

Introduction: Obesity is a multifactorial condition influenced by environment and genetic factors. Controlling appetite and satiety involves complex interactions between the hypothalamus, which is responsible for homeostasis regulation energy, and hormones that regulate appetite including leptin and ghrelin. Leptin plays an important role in the regulation of food intake and energy expenditure, generating an increase in energy burning and decreasing food intake. And ghrelin is directly involved in the regulation of short-term energy balance. Objectives: To verify frequency, biochemical profile and Body Mass Index (BMI) variations according to SNPs in LEPR and GHRL gene. Subjects and Methods: 163 both genders subjects were classified into Study Group (SG): 103 subjects with obesity; Control Group (CG): 60 non-obese. Blood samples were collected to perform DNA extraction and biochemical profile analysis. Statistical significance was established at p < 0.05. Results: The genotype and allele frequency were similar between groups for both polymorphisms. The _/A genotype of the GHRL rs696217 polymorphism was associated to increased BMI in SG compared CG (p = 0.003) and increased triglycerides (TG) and very low density lipoprotein (VLDLc) values in CG (p < 0, 05). The _/A genotype was also associated with increased fasting glucose compared to CC genotype only in CG (p = 0.031). Considering the LEPR rs1137101 polymorphism, AA genotype subjects presented higher BMI compared to _/G genotype subjects (p = 0.024). No difference between biochemical profile variables related to LEPR rs1137101 polymorphism was found. Conclusion: AA genotypes of the LEPR rs1137101 polymorphism and _/A of the GHRL rs696217 polymorphism suggest being risk factors for BMI and the latter is associated with fasting glucose, VLDLc and TG variation.
View complete article: PDF  |  Full-text

Identification of Novel De-Novo 12q14 -12q22 Gene Mutations and MTHFR C677T Gene Polymorphism Increase Genetic Susceptibility in Hirschsprung Disease - A Rare Case Report

View complete article: PDF  |  Full-text

The Presence of Minority HIV Drug Resistance Variants in The Protease and Gag Regions Confers Poor Response to Therapy Among Subtype A And D Patients

Objective: To determine the prevalence of minority drug resistance variants in the protease and Gag regions among patients failing a protease inhibitor (PI) based regimen with or without a susceptible genotype based on Sanger sequencing technology. Methods: Samples were obtained from patients who were failing on a protease inhibitor-based regimen (n = 500). Sanger based sequencing was performed as part of the standard of care. Mutation analysis was performed using the Stanford HIV drug Resistance database. A subset of these patient samples was grouped into two categories: those failing a PI based with mutations in the protease region (n = 100) and those failing on a PI based regimen without mutations in the protease region (n = 128). These samples were then analyzed in the protease and Gag regions using Next Generation Sequencing (NGS) technology and analysis of the drug resistance mutations was performed at the 20% and 1% cutoffs. Results: An initial analysis of the protease region for patients failing with drug resistance mutations revealed that most patients harbored mutations that confer resistance to Lopinavir and Atazanavir, but these mutations had little effect on Darunavir. Furthermore, NGS revealed that in patients failing with and without drug resistance mutations, minority drug resistance mutations were present at each of the drug resistance codons and at codons that confer multi-drug resistance to protease inhibitors. Further analysis of the Gag gene revealed more genetic diversity among patients failing with no mutations in the protease as evidenced by the proportion of polymorphisms at each codon. Conclusion: Based on Sanger sequencing, a proportion of patients fail a PI based regimen with a susceptible genotype. However, these patients harbor minority variants in the protease and numerous polymorphisms in the Gag region which when combined these could explain their poor response to therapy. Therefore, in order to improve patient care in low resource settings, there is need to adapt NGS as the standard genotyping technique so that minority variants are captured much earlier. In addition, since mutations in the Gag region also play a role in response to PIs, this region should be included in the routine monitoring for response to therapy in patients on a PI based regimen.
View complete article: PDF  |  Full-text

Development of SARS-Cov-2 Circulating Immune Complex Candidate, (CRCx) as A New Promising Vaccine Eliciting Broad Immune Response.

There is a need to develop a universal vaccine that can boost immunity to coronaviruses if some modifications in their structure occur. This is what we are dealing with nowadays: a virus that can mutate its structure, while immunity is standing still in facing the virus. We report on preclinical trials of CRCx 3 and CRCx 2 vaccine candidates in inducing an elevated level of positive neutralizing antibodies as well as a cellular immune response in an animal model to provide protection against SARS-CoV-2. Highly efficient protection against SARS-CoV-2 was obtained with three-dose immunization using 0.25 ml of CRCx vaccine with a 25-mm needle at 7-day intervals between successive injections. In addition, CRCx vaccine candidates exhibit efficient productivity and good genetic stability for vaccine manufacture. These results support the further evaluation of CRCx in a clinical trial.
View complete article: PDF  |  Full-text

Chemical Synthesis, Characterization of Ag, Au Nanoparticles and Formulation of Bimetallic Nanostructure onto Tri-block Copolymer Surfaces

View complete article: PDF  |  Full-text

Profile of Adult Lymphomas in Sub-Saharan Africa: A Monocentric Study of Histoimmunochemical Aspects

A total of 26 NHL patients (56.5%) and 20 LH cases (43.5%), aged 32-11 and 51-18 years respectively, were selected. Polyadenopathy was noted in 95% of cases of HL and 73.1% of cases of NHL (p=0.002). Patients were at Ann Arbor Stage II-IV in 80% of cases for the NHL and 70% of cases for LH (p: 0 ,317). Type B-Cell NHL entities were Diffuse Large Cell B Lymphoma (34.6%), Follicular Lymphoma (15.4%), Mantle Lymphoma (7.7%), Lymphocytic Lymphoma (7.7%), and Malt Lymphoma (3.8%). The NHL was type T-Cell in 30.8% of cases including 19.2% of anaplastic lymphoma. The HL were classic (80%) and nodular lymphocyte predominant Hodgkin lymphoma (20%). Specific treatment was performed in 82.6% of cases, 28.9% of which were immunochemotherapy. Remission was noted in 52.4% of NHL patients and 70.3% of those with HL.
View complete article: PDF  |  Full-text

Correlation of Hemostatic Parameters with Poly (ADP-ribose) Polymerase-1 (PARP-1) Polymorphisms, Mutations, Laboratory, and Clinical Characteristics in 114 Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Patients with Philadelphia-negative myeloproliferative neoplasms (PN-MPN) are at a higher risk for venous thrombosis. Thromboelastometry may prove efficient to evaluate the patient’s thrombotic risk. In this study, based on data from 114 patients with PN-MPN from a single center in Greece, hemostatic profile was assessed with routine coagulation tests, Rotational Thromboelastometry (ROTEM® ), and Platelet Function Analyzer (PFA)-100 and correlated with clinical, laboratory, treatment characteristics, gene mutations and polymorphisms of poly (ADP-ribose) polymerase-1 (PARP-1)
View complete article: PDF  |  Full-text

Multidetector CT Imaging of Squamous Cell Carcinoma of Buccal Mucosa

This study aims at describing the CT imaging findings and role of multidetector computed tomography (MDCT) in evaluation of squamous cell carcinoma of buccal mucosa and its staging. The imaging findings in squamous cell carcinoma (SCC) of the oral cavity allow the radiologist to accurately determine the extent and staging of disease thereby help clinicians plan appropriate treatment.
View complete article: PDF  |  Full-text

Plasma Exchange for Neuroborreliosis Associated with Guillain Barre Syndrome

Lyme neuroborreliosis (LNB) is a rare infectious disorder of the nervous system caused by Borrelia burgdorferi spirochetes. Different neurological conditions were reported in the disease.
View complete article: PDF  |  Full-text

A Giant Cystadenolymphoma of the Parotid Gland: Case Report

View complete article: PDF  |  Full-text

Small Cell Variant of Anaplastic Large Cell Lymphoma Presenting As Leukaemia: A Case Report and Review of Literature

Anaplastic large cell lymphoma with a small cell pattern is a rare T-cell lymphoma. This condition is frequently seen in young patients and should be considered in patients presenting with leucocytosis and constitutional symptoms. We report a case of small cell variant (SCV) of ALCL in a 68 year old man diagnosed by ALK immunohistochemistry (IHC) and cytogenetic analysis. The limitations of using only morphology in diagnosing this rare variant, has also been emphasised.
View complete article: PDF  |  Full-text

Evaluating the Economic Performance of Reverse Polymerization Technology for Waste Tyre Recycling in Sub-Saharan Africa

The unlawful and uncontrolled disposal of waste tyres is greatly disturbing in terms of the environmental concerns and the economic misfortune. In combating this menace, there is growing interest in the application of efficient and environmental-friendly alternatives to the traditional recycling methods for waste tyres. Pyrolysis can be considered as an appropriate non-conventional method for complex materials such as tyres. Several works have been made to improve pyrolysis process towards higher yield and quality of biofuels and greater energy efficiency. This study considers Reverse Polymerization, a microwave-assisted pyrolysis process to extract complete yield and higher quality of valuable products, while avoiding toxic emissions into the environment. The feasibility of such innovative recycling process in Sub-Sahara Africa is essential in order to convince concerned authorities to buy into such advanced technologies with great benefits. The investment analysis and economic performance indicators from the study demonstrated that the operation of such proposed recycling system in the continent is economically feasible. However, the operation of such facility under the present market conditions might highly be challenged by high investment risk as the project is highly capital intensive.
View complete article: PDF  |  Full-text

Electronic-nose Applications in Forensic Science and for Analysis of Volatile Biomarkers in the Human Breath

The application of electronic-nose (E-nose) technologies in forensic science is a recent new development following a long history of progress in the development of diverse applications in the related biomedical and pharmaceutical fields. Data from forensic analyses must satisfy the needs and requirements of both the scientific and legal communities. The type of data collected from electronic-nose devices provides a means of identifying specific types of information about the chemical nature of evidentiary objects and samples under investigation using aroma signature profiles of complex gaseous mixtures containing volatile organic compounds (VOCs) released from manufactured products and parts of the human body. E-nose analyses also provide useful qualitative information about the physicochemical characteristics and metabolic conditions of human subjects without the need for time-consuming analyses to identify all chemical components in human-derived volatile mixtures.
View complete article: PDF  |  Full-text


Editorial Board Members Related to LYM

M. Sukumar

Professor
Centre for Food Technology
Anna University
India

Khaldon Bodoor

Associate Professor
Department of Biotechnology and Genetic Engineering
Jordan University of Science and Technology
Jordan

Scott Asbill

Professor of Pharmaceutics
College of Pharmacy & Health Sciences
Campbell University
United States

Kell Mortensen

Professor
Niels Bohr Institute
University of Copenhagen
Denmark

Yun Dai

Associate Professor
Department of Medicine
Virginia Commonwealth University
United States

Julie Teruya-Feldstein

Director
Hematopathology
Immunohistochemistry Laboratory
United States

Nallasivam Palanisamy

Associate Professor
Michigan Center for Translational Pathology
University of Michigan
United States

Mohamed Khayet

Professor
Department of Applied Physics
Complutense University of Madrid
Spain

Paraj V. Mandrekar

Research Scientist
Genetic Identity team
Promega Corporation
United States

Bin Zhou

Scientist
J. Craig Venter Institute
United States
Submit Manuscript